✦ LIBER ✦

A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer

✍ Scribed by M. Michael, J. Zalcberg, P. Gibbs, L. Lipton…

Book ID: 120776565
Publisher: Springer
Year: 2012
Tongue: English
Weight: 251 KB
Volume: 71
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-2009-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase Ib Study of Drozitumab Combined Wi

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

✍ Rocha Lima, Caio M.; Bayraktar, Soley; Flores, Aurea M.; MacIntyre, Jessica; Mon 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 223 KB

Phase I/II trial of capecitabine and oxa

Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205

✍ Hoehler, T; von Wichert, G; Schimanski, C; Kanzler, S; Moehler, M H; Hinke, A; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 202 KB

Cediranib With mFOLFOX6 Versus Bevacizum

Cediranib With mFOLFOX6 Versus Bevacizumab With mFOLFOX6 As First-Line Treatment for Patients With Advanced Colorectal Cancer: A Double-Blind, Randomized Phase III Study (HORIZON III)

✍ Schmoll, H.-J.; Cunningham, D.; Sobrero, A.; Karapetis, C. S.; Rougier, P.; Kosk 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

A phase 1 trial of imatinib, bevacizumab

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

✍ Kelley, R K; Hwang, J; Magbanua, M J M; Watt, L; Beumer, J H; Christner, S M; Ba 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 360 KB

Phase I results from a two-part Phase I/

Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer

✍ Taroh Satoh, Kensei Yamaguchi, Narikazu Boku, Wataru Okamoto, Tomotaka Shimamura 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 204 KB

Randomized Phase II Open-Label Study of

Randomized Phase II Open-Label Study of mFOLFOX6 in Combination With Linifanib or Bevacizumab for Metastatic Colorectal Cancer

✍ O'Neil, Bert H.; Cainap, Calin; Van Cutsem, Eric; Gorbunova, Vera; Karapetis, Ch 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 911 KB